Surgical system and methods of use

US11944825B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11944825-B2
Application numberUS-202117142666-A
CountryUS
Kind codeB2
Filing dateJan 6, 2021
Priority dateJan 6, 2021
Publication dateApr 2, 2024
Grant dateApr 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of manufacturing a surgical device including providing a substrate having opposite first and second sides. The second side having a first section and a second section. Coupling a substrate to a fixture such that the first side faces the fixture and depositing a gel onto the second side such that the gel coats the first section without coating the second section.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of manufacturing a surgical device, the method comprising: providing a substrate having opposite first and second sides, the second side having a first section and a second section; coupling a substrate to a fixture such that the first side faces the fixture; and depositing a gel onto the second side such that the gel coats the first section without coating the second section, the gel comprising a hemostatic agent suspended in a solution, the solution comprising collagen, water and glycerol. 2. The method recited in claim 1 , wherein depositing the gel onto the second side comprises 3D printing the gel onto the second side. 3. The method recited in claim 1 , wherein depositing the gel onto the second side is controlled by a robot. 4. The method recited in claim 1 , wherein the first section comprises a plurality of first sections that are spaced apart from one another by the second section. 5. The method recited in claim 1 , wherein the first section comprises a plurality of first sections that are spaced apart from one another by the second section, the first sections each having the same shape. 6. The method recited in claim 1 , wherein the first section comprises a plurality of first rows that are spaced apart from one another by the second section. 7. The method recited in claim 1 , wherein depositing the gel onto the second side includes depositing a first gel onto the second side and depositing a second gel onto the first side, the first gel having a color that is different than a color of the second gel. 8. The method recited in claim 1 , wherein the substrate is an absorbable antibacterial envelope. 9. The method recited in claim 1 , wherein the gel consists of the hemostatic agent suspended in solution, the solution consisting of collagen, water and glycerol. 10. The method recited in claim 1 , wherein the hemostatic agent comprises trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ). 11. The method recited in claim 1 , wherein the hemostatic agent consists of trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ). 12. The method recited in claim 1 , wherein the first section defines at least a portion of a perimeter of the substrate. 13. The method recited in claim 1 , wherein the hemostatic agent includes epinephrine. 14. The method recited in claim 1 , wherein the hemostatic agent includes tranexamic acid. 15. The method recited in claim 1 , wherein the hemostatic agent includes collagen. 16. The method recited in claim 1 , wherein the hemostatic agent includes acid soluble collagen. 17. The method recited in claim 1 , wherein the hemostatic agent includes chitosan. 18. The method recited in claim 1 , wherein the hemostatic agent includes oxidized regenerated cellulose. 19. A method of manufacturing a surgical device, the method comprising: providing a substrate having opposite first and second sides, the second side having a first section and a second section, wherein the substrate is an absorbable antibacterial envelope; coupling a substrate to a fixture such that the first side faces the fixture; and 3D printing a gel onto the second side such that the gel coats the first section without coating the second section, wherein the first section comprises a plurality of first sections that are spaced apart from one another by the second section, and wherein the gel consists of trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ) suspended in a solution, the solution consisting of collagen, water and glycerol. 20. A method of manufacturing a surgical device, the method comprising: providing a substrate having opposite first and second sides, the second side having a first section and a second section, wherein the substrate is an absorbable antibacterial envelope; coupling a substrate to a fixture such that the first side faces the fixture; and depositing a gel onto the second side using a robot such that the gel coats the first section without coating the second section, wherein the first section comprises a plurality of first sections that are spaced apart from one another by the second section, and wherein the gel consists of trans-4-(aminomethyl)cyclohexanecarboxylic acid (C 8 H 15 NO 2 ) suspended in a solution, the solution consisting of collagen, water and glycerol.

Assignees

Inventors

Classifications

  • A61N1/375Primary

    Constructional arrangements, e.g. casings · CPC title

  • Products made by additive manufacturing · CPC title

  • Macromolecular gels · CPC title

  • Polyhydroxylic alcohols · CPC title

  • containing COOH-groups; Esters or salts thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11944825B2 cover?
A method of manufacturing a surgical device including providing a substrate having opposite first and second sides. The second side having a first section and a second section. Coupling a substrate to a fixture such that the first side faces the fixture and depositing a gel onto the second side such that the gel coats the first section without coating the second section.
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/375. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).